| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.007 |